Characterization of resistance mutations against HCV ketoamide protease inhibitors

Antiviral Research
Xiao TongRobert Ralston

Abstract

An issue of clinical importance in the development of new antivirals for HCV is emergence of resistance. Several resistance loci to ketoamide inhibitors of the NS3/4A protease have been identified (residues V36, T54, R155, A156, and V170) by replicon and clinical studies. Using SCH 567312, a more potent protease inhibitor derived from SCH 503034 (boceprevir) series, we identified two new positions (Q41 and F43) that confer resistance to the ketoamide class. The catalytic efficiency of protease enzymes was not affected by most resistance mutations, whereas replicon fitness varied with specific mutations. SCH 503034 and another ketoamide inhibitor, VX-950 (telaprevir), showed moderate losses of activity against most resistance mutations (< or =10-fold); the highest resistance level was conferred by mutations at A156 locus. Although SCH 503034 and VX-950 bind similarly to the active site, differences in resistance level were observed with specific mutations. Changes at V36 and R155 had more severe impact on VX-950, whereas mutations at Q41, F43 and V170 conferred higher resistance to SCH 503034. Structural analysis of resistance mutations on inhibitor binding is discussed.

Citations

Dec 14, 2011·Current Gastroenterology Reports·Maya Gambarin-Gelwan, Ira M Jacobson
Nov 11, 2010·Hepatology International·Tatsuo KandaOsamu Yokosuka
Nov 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Keith P RomanoCelia A Schiffer
Jun 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Margaret RobinsonAndrew E Greenstein
Nov 12, 2009·The Journal of Antimicrobial Chemotherapy·Tara L KiefferGaston R Picchio
Apr 18, 2012·Antimicrobial Agents and Chemotherapy·Fiona McPheeClaudio Pasquinelli
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Andrew BaeHongmei Mo
Aug 8, 2012·Antimicrobial Agents and Chemotherapy·Mohsan SaeedCharles M Rice
Feb 24, 2010·Antimicrobial Agents and Chemotherapy·Oliver LenzKenneth A Simmen
Oct 26, 2011·Antimicrobial Agents and Chemotherapy·Lisette LagacéGeorge Kukolj
Feb 22, 2013·Journal of Clinical Microbiology·Sophie ValletJean-Michel Pawlotsky
Feb 27, 2013·Memórias do Instituto Oswaldo Cruz·Luciana Bonome ZeminianRejane Maria Tommasini Grotto
Dec 17, 2009·Expert Opinion on Investigational Drugs·Ivan GentileGuglielmo Borgia
Nov 28, 2012·Clinics in Liver Disease·Anushree ChatterjeeAlan S Perelson
Dec 29, 2015·Journal of Photochemistry and Photobiology. B, Biology·Farooq Ali ShahNoor ud Din
Dec 17, 2009·Gastroenterology·Christoph Sarrazin, Stefan Zeuzem
Oct 25, 2008·Antiviral Research·Mark A Wainberg
Oct 23, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Stefania PaolucciFausto Baldanti
May 28, 2009·Journal of Viral Hepatitis·A J V Thompson, J G McHutchison
Mar 6, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Silvana GaudieriMichaela Lucas
Feb 3, 2009·Alimentary Pharmacology & Therapeutics·A J V Thompson, J G McHutchison
Nov 26, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thomas KuntzenTodd M Allen
Apr 12, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ingrid Imhof, Peter Simmonds
Aug 2, 2012·Advances in Virology·Cristina Simona Strahotin, Michael Babich
Sep 30, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Simone SusserChristoph Sarrazin
Mar 7, 2014·Journal of Viral Hepatitis·D L Wyles, J A Gutierrez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.